References
- Accuracy of the references is the responsibility of the authors.
- Oral erythromycins. Med Lett 1985: 27(678): 1–3
- Washington JA 2d, Wilson WR. Erythromycin: a microbial and clinical perspective after 30 years of clinical use. Part 1. Mayo Clin Proc 1985: 60(Mar): 189–203
- Washington JA 2d, Wilson WR. Erythromycin: a microbial and clinical perspective after 30 years of clinical use. Part 2. Mayo Clin Proc 1985: 60(Apr): 271–8
- Neu HC. The development of macrolides: clarithromycin in perspective. J Antimicrob Chemother 1991: 27(Suppl A): 1–9
- Kirst HA, Sides GD. New directions for macrolide antibiotics: structural modifications and in vitro activity. Antimicrob Agents Chemother 1989: 33(9): 1413–8
- Kirst HA, Sides GD. New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrob Agents Chemother 1989: 33(9): 1419–22
- Hardy DJ, Hensey DM, Beyer JM, et al. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother 1988: 32(11): 1710–9
- Retsema J, Girard A, Schelkly W, et al. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother 1987: 31(12): 1939–47
- Hardy DJ, Swanson RN, Rode RA, et al. Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenza by 14-hydroxy-clarithromycin, its major metabolite in humans. Antimicrob Agents Chemother 1990: 34(7): 1407–13
- Schentag JJ, Ballow CH. Tissue-directed pharmacokinetics. Am J Med 1991: 91(Suppl 3A): 5–11S
- Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990: 25(Suppl A): 73–82
- Fraschini F, Scaglione F, Pintucci G, et al. The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans. J Antimicrob Chemother 1991: 27(Suppl A): 61–5
- Bachand RT Jr. A comparative study of clarithromycin and penicillin VK in the treatment of outpatients with streptococcal pharyngitis. J Antimicrob Chemother 1991: 27(Suppl A): 75–82
- Hooton TM. A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. Am J Med 1991: 91(Suppl 3A): 23–6S
- Karma P, Pukander J, Penttila M, et al. The comparative efficacy and safety of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitis. J Antimicrob Chemother 1991: 27(Suppl A): 83–90
- Casiano RR. Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis. Am J Med 1991: 91(Suppl 3A): 27–30S
- Bachand RT Jr. Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis. J Antimicrob Chemother 1991: 27(Suppl A): 91–100
- Dark D. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections. Am J Med 1991: 91(Suppl 3A): 31–5S
- Anderson G, Esmonde TS, Coles S, et al. A comparative safety and efficacy study of clarithromycin and erthromycin stearate in community-acquired pneumonia. J Antimicrob Chemother 1991: 27(Suppl A): 117–24
- Cassell GH, Drnec J, Waites KB, et al. Efficacy of clarithromycin against Mycoplasma pneumoniae. J Antimicrob Chemother 1991: 27(Suppl A): 47–59
- Schönwald S, Gunjaca M, Kolacny-Babić L, et al. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. J Antimicrob Chemother 1990: 25(Suppl A): 123–6
- Mallory SB. Azithromycin compared with cephalexin in the treatment of skin and skin structure infections. Am J Med 1991: 91(Suppl 3A): 36–9S
- Steingrimsson O, Olafsson JH, Thorarinsson H, et al. Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chemother 1990: 25(Suppl A): 109–14
- Young LS, Wiviott L, Wu M, et al. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet 1991: 338(Nov 2): 1107–9
- Dautzenberg B, TrufFot C, Legris S, et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome: a controlled clinical trial. Am Rev Respir Dis 1991: 144: 564–9
- Fernandez-Martin J, Leport C, Morlat P, et al. Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS. Antimicrob Agents Chemother 1991: 35(10): 2049–52
- Carter BL, Woodhead JC, Cole KJ, et al. Gastrointestinal side effects with erythromycin preparations. Drug Intell Clin Pharm 1987: 21(Sep): 734–8
- Hopkins S. Clinical toleration and safety of azithromycin. Am J Med 1991: 91(Suppl 3A): 40–5S